1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidinyl)-1-nitrosourea has been researched along with Carcinoma, Small Cell in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chapman, RA; Natale, RB; Wittes, RE; Young, CW | 1 |
| Casper, ES; Gordon, C; Gralla, RJ; Kalman, LA; Kris, MG; Woodcock, TM | 1 |
2 other study(ies) available for 1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidinyl)-1-nitrosourea and Carcinoma, Small Cell
| Article | Year |
|---|---|
Phase II trial of 1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidyl)-1-nitrosourea in small cell cancer of the lung.
Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Small Cell; Drug Evaluation; Female; Humans; Lung Neoplasms; Male; Middle Aged; Nitrosourea Compounds; Thrombocytopenia | 1984 |
Phase I trial of PCNU.
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Small Cell; Drug Evaluation; Female; Glioma; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Nausea; Neoplasms; Nitrosourea Compounds; Thrombocytopenia | 1983 |